• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4705975)   Today's Articles (287)
For: Kannarr S, El-Harazi SM, Moshirfar M, Lievens C, Kim JL, Peace JH, Safyan E, Liu H, Zheng S, Robinson MR. Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study. Am J Ophthalmol 2023;253:189-200. [PMID: 37149245 DOI: 10.1016/j.ajo.2023.05.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Revised: 04/19/2023] [Accepted: 05/01/2023] [Indexed: 05/08/2023]
Number Cited by Other Article(s)
1
Parsa CF. New Sight for Old: Commentary On the Use of Pilocarpine for Presbyopia. J Ophthalmic Vis Res 2024;19:392-396. [PMID: 39917451 PMCID: PMC11795007 DOI: 10.18502/jovr.v19i4.17786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2024] [Accepted: 08/16/2024] [Indexed: 02/09/2025]  Open
2
Farid M, Rowen SL, Moshirfar M, Cunningham D, Gaddie IB, Smits G, Ignacio T, Gupta PK. Combination Low-Dose Pilocarpine/Diclofenac Sodium and Pilocarpine Alone for Presbyopia: Results of a Randomized Phase 2b Clinical Trial. Clin Ophthalmol 2024;18:3425-3439. [PMID: 39606177 PMCID: PMC11600938 DOI: 10.2147/opth.s476658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2024] [Accepted: 10/31/2024] [Indexed: 11/29/2024]  Open
3
Zhang X, Xiong X, Zhang H, Huang T, Zhou X. Pilocarpine in the Treatment of Presbyopia: Progress, Issues, and Future Prospects. Drugs Aging 2024;41:897-906. [PMID: 39455529 DOI: 10.1007/s40266-024-01155-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/06/2024] [Indexed: 10/28/2024]
4
Grzybowski A, Kapitanovaite L, Zemaitiene R. An updated systematic review of pharmacological treatments for presbyopia. ADVANCES IN OPHTHALMOLOGY PRACTICE AND RESEARCH 2024;4:220-225. [PMID: 39512930 PMCID: PMC11541684 DOI: 10.1016/j.aopr.2024.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Revised: 08/17/2024] [Accepted: 09/03/2024] [Indexed: 11/15/2024]
5
Novack GD, Robin AL. Ocular Pharmacology. J Clin Pharmacol 2024;64:1068-1082. [PMID: 38708561 DOI: 10.1002/jcph.2451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Accepted: 04/08/2024] [Indexed: 05/07/2024]
6
Gawel K, Hulas-Stasiak M, Marszalek-Grabska M, Grenda A, Siekierska A, Kosheva N, van der Ent W, Esguerra CV, Krawczyk P, Turski WA. Induction of seizures and initiation of epileptogenesis by pilocarpine in zebrafish larvae. Front Mol Neurosci 2024;17:1418606. [PMID: 39165716 PMCID: PMC11333333 DOI: 10.3389/fnmol.2024.1418606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Accepted: 06/19/2024] [Indexed: 08/22/2024]  Open
7
Fernández Jiménez-Ortiz H, Toledano Fernández N. Pharmacological treatments for the correction of presbyopia. ARCHIVOS DE LA SOCIEDAD ESPANOLA DE OFTALMOLOGIA 2024;99:331-339. [PMID: 38663714 DOI: 10.1016/j.oftale.2024.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 03/10/2024] [Indexed: 04/29/2024]
8
Zanjani A, Sohrabi MR, Kabiri Fard H. Colorimetric Concurrent Determination of Ultra-Trace Amounts of Pilocarpine and Timolol as Anti-Glaucoma Drugs in Binary Mixtures Using a Multivariate Calibration Approach Based on the Aggregation of Gold Nanoparticles. J AOAC Int 2024;107:592-599. [PMID: 38608200 DOI: 10.1093/jaoacint/qsae030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Revised: 03/24/2024] [Accepted: 04/01/2024] [Indexed: 04/14/2024]
9
Shafer BM, McGee SR, Ifantides C, Williamson BK, Kannarr S, Whyte J, Zhang Z, Yanke T, Schachter S. Understanding Perspectives on Presbyopia and Use of Pilocarpine HCl 1.25% Twice Daily from Participants of the Phase 3 VIRGO Study. Ophthalmol Ther 2024;13:1723-1742. [PMID: 38662193 PMCID: PMC11109051 DOI: 10.1007/s40123-024-00935-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 03/12/2024] [Indexed: 04/26/2024]  Open
10
Ayaki M, Hanyuda A, Negishi K. Symptomatic Presbyopia may Develop Earlier in Patients With Glaucoma-A Cross-Sectional Retrospective Cohort Study. Transl Vis Sci Technol 2024;13:21. [PMID: 38619925 PMCID: PMC11037495 DOI: 10.1167/tvst.13.4.21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 03/04/2024] [Indexed: 04/17/2024]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA